16571-256-69 : NDC 2026 Code

16571-256-69 : Clindamycin Phosphate ( Clindamycin Phosphate )

Additionally :

You can get information about “16571-256-69” NDC code in 16571-256-69 in HTML format

HTML | 16571-256-69 in TXT (Plain Text) format

TXT | 16571-256-69 in PDF (Portable Document Format)

PDF | 16571-256-69 in XML format

XML formats.

NDC Code : 16571-256-69 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "16571-256-69",
    "PackageDescription": "69 APPLICATOR in 1 JAR (16571-256-69)  / 1 mL in 1 APPLICATOR",
    "NDC11Code": "16571-0256-69",
    "ProductNDC": "16571-256",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Clindamycin Phosphate",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Clindamycin Phosphate",
    "DosageFormName": "SOLUTION",
    "RouteName": "TOPICAL",
    "StartMarketingDate": "20260323",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA218300",
    "LabelerName": "Rising Pharma Holdings, Inc.",
    "SubstanceName": "CLINDAMYCIN PHOSPHATE",
    "StrengthNumber": "10",
    "StrengthUnit": "mg/mL",
    "Pharm_Classes": "Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2026-03-26",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20271231",
    "StartMarketingDatePackage": "20260323",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}